Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-22 Purchase | 2024-07-22 8:26 pm | Artiva Biotherapeutics Inc. | ARTV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner | 416,666 | $12 | $4,999,992 | 2,398,324 (Direct) | View |
| 2022-05-25 Sale | 2022-05-27 7:20 pm | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 702,737 | $4.1236 | $2,897,806 | 1,905,430 (Direct) | View |
| 2021-10-25 Purchase | 2021-10-25 7:40 pm | Ventyx Biosciences Inc. | VTYX | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner | 312,500 | $16 | $5,000,000 | 5,011,536 (Indirect Direct) | View |
| 2021-06-29 Purchase | 2021-07-01 5:27 pm | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 625,000 | $16 | $10,000,000 | 2,608,167 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion